HomeMerck SeronoContact UsGlossaryReferencesSearchSite Guide
			Concern Treatment Pregnancy Experiences About Serono International Offices History of Serono in Fertility Legal Statement		Welcome to fertilityasia.com   Thank you for visiting us. We hope that you find this site informative, useful - and inspiring.  fertilityasia.com was created by Serono to serve as the definitive information web site for people with concerns about infertility. We are a global biotechnology leader with over 4,900 employees worldwide. Serono has eight biotechnology products on the market and a strong pipeline with over 30 on-going development projects. We have products available in four core therapeutic areas: Reproductive health:  where we are the world leader in infertility treatment. Neurology:  where Rebif® is a leading treatment for relapsing forms of multiple sclerosis, outside the United States. Growth and metabolism treatments:  for pediatric and adult growth deficiencies, as well as AIDS wasting and Dermatology:  where Serono is poised to enter this new therapeutic area with the approval of Raptiva® (efalizumab), for moderate-to-severe psoriasis. Serono has an integrated Research & Development capability in-house, as well as a network of biotech alliances with smaller biotech companies and academic groups. The Company employs over 1,300 R&D personnel, and over 24% of total revenues in 2004 were invested in discovering and developing new therapeutics. The pipeline includes both recombinant proteins and small molecules, focusing on the existing therapeutic areas, as well as new targets, such as oncology and autoimmune diseases.  The Company currently operates in 44 countries, with production facilities in eight countries and sales in over 90 countries.
			© 2003-2008 Merck Serono S.A. Please read our Legal Statement. US residents should consult the Serono, Inc. fertility website at www.fertilitylifelines.com Last updated: 14/05/2008